Cargando…
Low- Versus High-dose Cyclophosphamide in Class III/IV Lupus Nephritis: A Retrospective Study from South Asia
INTRODUCTION: The comparative efficacy of low-dose cyclophosphamide (LD-CYC) and high-dose cyclophosphamide (HD-CYC) for treatment of lupus in South Asians is not well established. We aimed to compare treatment outcomes in South Asian patients with class III and IV lupus nephritis treated with eithe...
Autores principales: | Wijayaratne, Dilushi Rowena, Atukorala, Inoshi Gunetilleke, Gunawardena, Nalika S., Wijesundara, Devasmitha A., Lanerolle, Rushika Dinal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185022/ https://www.ncbi.nlm.nih.gov/pubmed/37197037 http://dx.doi.org/10.4103/ijn.ijn_73_22 |
Ejemplares similares
-
Dengue hemorrhagic fever with bleeding and fluid overload in a patient with active lupus nephritis: a case report of diagnostic and therapeutic challenges
por: Vidanapathirana, Manudi, et al.
Publicado: (2023) -
Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018) -
Revisited Cyclophosphamide in the Treatment of Lupus Nephritis
por: Quan, Xiao-ying, et al.
Publicado: (2022) -
A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis
por: Rankothgedera, Sakuni, et al.
Publicado: (2021) -
Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)